Business Trip Report - Korea @ Dec-2025
posted: 05-Jan-2026 & updated: 06-Jan-2026
Report prepared by Sunghee Yun
Initial draft on 05-Jan-2026
Final Revised on 06-Jan-2026
Trip Overview
Korea • December 9-21, 2025 (12 nights) • Sunghee Yun
Conference-intensive 12-night trip anchoring year-end partnerships and government relations. During this trip, Sunghee
- attended AI-BioX ConfEX Grand Summit 2025 (2-day premier biotech/AI conference)
- formalized Keimyung University Dongsan Hospital joint development with 이시욱 교수 (MD/Professor/CEO) 강혜인 교수 (MD/Professor, Clinical Laboratory Medicine)
- obtained strong endorsement from 김준혁 의원 (National Assembly Member) at SNUBH meeting
- received SNUBH Head introduction promise (진단검사의학과 major)
- secured 가천대의대 (Gachon University College of Medicine) introduction from 김용석 원장
- secured 나은병원 (Naeun Hospital, Incheon Songdo) introduction from 김영웅 대표
- networked with 50+ biotech/medical/AI professionals at AI-BioX Conference
- served as judge for Researchthon evaluating 10 research teams
- participated in VIP lunch and Science & Technology Talent Ecosystem Town Hall
- connected with Forest Partners (황호연 GP) for investment landscape insights
- advanced KAIST partnership discussions with 임채권 교수
- strengthened LULUMEDIC partnership through multiple meetings
Basic Logistics
Dates - December 9-21, 2025 (12 nights)
Flights
- Outbound - United 893, SFO → ICN (departed Dec 9 @ 10:30am PST, arrived Dec 10 @ 4:15pm KST, 13h)
- Return - OZ 212, ICN → SFO (departed Dec 21 @ 8:47pm KST, arrived Dec 21 @ 2:13pm PST, 10h 26m)
Base - Suji, Gyeonggi-do
Regional Trip
- Dec 15 - Day trip to Daegu for Keimyung University Dongsan Hospital
- KTX 072: Gwangmyeong Station → Dongdaegu Station (12:17pm → 1:47pm)
- KTX 218: Dongdaegu Station → Gwangmyeong Station (7:12pm → 8:46pm)
ACTION ITEMS
| Owner | Deliverable | Deadline | Status |
|---|---|---|---|
| Sunghee Yun / Jin Young Heo | Execute joint development agreement with Keimyung University Dongsan Hospital with 이시욱 교수, 강혜인 교수, 김도훈 교수 (Laboratory Medicine) | Q1-2026 | In Progress |
| Sunghee Yun / Kee-Hyun Paik | Initiate PoC at Keimyung preliminary testing environment for biochip validation | Q1-2026 | In Progress |
| Sunghee Yun | Meet SNUBH Head (진단검사의학과 major) - arranged by 신원순/조병주 | Next trip Q1-2026 | Scheduled |
| Sunghee Yun / Jin Young Heo | Find and contract CRO for SNUBH IRB process | Q1-2026 | In Progress |
| Sunghee Yun | Follow up with 김영웅 대표 on 나은병원 (Naeun Hospital, Incheon Songdo) introduction | Q1-2026 | In Progress |
| Sunghee Yun | Meet 가천대의대 (Gachon University College of Medicine) - introduced by 김용석 원장 | Q1-2026 | In Progress |
| Sunghee Yun / Kee-Hyun Paik | Finalize partnership terms with LULUMEDIC | Q1-2026 | In Progress |
| Sunghee Yun / Kee-Hyun Paik | Advance collaboration with MaiT (이시욱 대표, 한봉주 QA Lead) on technical and commercial fronts | Q1-2026 | In Progress |
| Sunghee Yun | Follow up with 임채권 교수 (KAIST) on Silicon Valley visit and KAIST-Erudio Bio partnership | Q1-2026 | In Progress |
| Sunghee Yun | Engage with 황호연 (General Partner, Forest Partners) for potential investment discussions | Q1-2026 | Pending |
| Sunghee Yun | Leverage AI-BioX Conference network - follow up with key contacts from Johns Hopkins, Cambridge, Cedars-Sinai, SNU, etc. | Q1-2026 | In Progress |
| Sunghee Yun | Connect with 김종일 (Director, SNU Medicine Biochemistry & Molecular Biology) for research collaboration | Q1-2026 | Pending |
| Sunghee Yun | Follow up with 황재선 (VP, SK Bioscience Digital Innovation) from Town Hall meeting | Q1-2026 | Pending |
MILESTONES & TIMELINE
Immediate (Dec 2025)
- ✅ AI-BioX ConfEX Grand Summit 2025 participation completed (2 days)
- ✅ Keimyung University Dongsan Hospital joint development formalized with 이시욱 교수, 강혜인 교수, 김도훈 교수
- ✅ Keimyung preliminary testing environment (PoC) secured
- ✅ 김준혁 의원 strong endorsement obtained at SNUBH meeting
- ✅ SNUBH Head meeting arranged for next trip
- ✅ 나은병원 introduction secured from 김영웅 대표
- ✅ 가천대의대 introduction secured from 김용석 원장
- ✅ Researchthon judge participation completed (10 teams evaluated)
- ✅ 50+ biotech/AI professional network expanded
- ✅ Forest Partners investment landscape meeting
- 🔄 CRO search for SNUBH IRB process
Short-term (Q1 2026)
- Keimyung joint development agreement executed
- PoC initiated at Keimyung preliminary testing environment
- SNUBH Head meeting completed
- CRO contracted for IRB process
- 나은병원 partnership discussions initiated
- 가천대의대 collaboration explored
- LULUMEDIC partnership finalized
- MaiT technical/commercial collaboration advanced
Medium-term (2026):
- Four hospital partnerships operational (SNUBH, Seoul Asan, Keimyung, 나은병원/가천대)
- IRB approvals progressing through CRO support
- Keimyung PoC results validating technology
- Clinical data generation from multiple hospital sites
- National Assembly support leveraged for regulatory advantages
- Investment secured through expanded investor network
- KAIST partnership framework defined
STRATEGIC INSIGHTS
- Four-Hospital Network Strategy Crystallizing:
- SNUBH (Seoul National University Bundang Hospital) - IRB in progress, National Assembly support
- Keimyung University Dongsan Hospital - Joint development formalized, PoC environment secured
- Seoul Asan Hospital - Asan Foundation (김인재) ready when timing appropriate
- 나은병원 (Naeun Hospital, Incheon Songdo) - Introduction by 김영웅, pending engagement
- 가천대의대 (Gachon University College of Medicine) - Introduction by 김용석, pending engagement
- Geographic diversity (Seoul, Bundang, Daegu, Incheon) + institutional variety (national university, private hospital, medical school) creates robust validation network
- National Assembly Endorsement - Political Capital:
- 김준혁 의원 (Deputy Floor Leader, Democratic Party) stated “utmost confidence” in Erudio Bio’s technology, marketability, product value, profitability
- Direct quote: “understood our technology and would help us in whatever way he could”
- Meeting at SNUBH demonstrates political support at clinical collaboration site
- Complements Suwon 특구 invitation from same 의원 (Nov trip)
- National Assembly endorsement provides regulatory advantages and government funding access
- Keimyung PoC Environment - De-Risking Technology:
- Preliminary testing environment offered before full joint development execution
- PoC phase allows technology validation with minimal resource commitment
- De-risks partnership for both sides
- Success in PoC creates momentum for expanded collaboration
- 강혜인 교수 (Laboratory Medicine) engagement fulfills Nov promise from 이시욱 대표
- AI-BioX Conference - Ecosystem Integration:
- Premier 2-day conference with 50+ high-quality contacts
- International reach - Johns Hopkins (김덕호), Cambridge (한남식), Cedars-Sinai (원경재)
- Domestic institutions - SNU Medicine, Korea University, 건국대, 광운대, 충남대, 동국대
- Industry - SK Bioscience (황재선), 백스다임, 오가노플러스, LSK Investment
- Government - National Assembly (이해민 의원, 김남희 의원), Suwon City (김지영, 김성진, 황인수)
- VIP lunch, Town Hall participation, Researchthon judge role = thought leader positioning
- CRO Strategy - IRB Process Acceleration:
- Dec 13 dinner decision to find/contract CRO for SNUBH IRB
- Professional CRO support accelerates regulatory approval
- Expertise in MFDS/KFDA processes critical for biochip medical equipment category
- Reduces burden on internal team
- Multiple hospital IRBs will benefit from CRO expertise
- Hospital Introduction Chain Reaction:
- 김영웅 대표 introducing 나은병원 (after multiple LULUMEDIC meetings across trips)
- 김용석 원장 introducing 가천대의대 (after single lunch meeting)
- Each hospital partnership creates credibility for next introduction
- Network effects accelerating - easier to get introductions as validation grows
- Hospital administrators/professors see peer institutions engaging with Erudio Bio
- SNUBH Head Meeting - Institutional Commitment Signal:
- SNUBH Head has 진단검사의학과 major (Laboratory Medicine background)
- Perfect alignment with Erudio Bio’s diagnostic focus
- Head-level meeting indicates institutional (not just professor) commitment
- Meeting arranged by 신원순 (정책국장) and 조병주 (연구행정팀장) - administrative leadership
- Institutional support critical for sustained collaboration beyond individual professors
- Researchthon Judge Role - Thought Leadership:
- Evaluated 10 research teams in biotech/medical science/AI
- Judge role positions Sunghee as expert evaluator (not just participant)
- Mentoring students at finale dinner extends influence to next generation
- Students remember judges who provided valuable feedback
- Talent pipeline for future hiring as Erudio Bio scales
- Science & Technology Talent Ecosystem Town Hall:
- Participated alongside SK Bioscience VP (황재선), 광운대 Graduate School Dean (김남영), KAIST Professor (정재승)
- Town Hall format = policy/strategy level (not just technical)
- Positions Sunghee as ecosystem builder, not just company founder
- Government/industry/academia representation in Town Hall = triple helix model
- Insights into Korea’s talent development strategy inform Erudio Bio hiring
- Investment Landscape Intelligence:
- 황호연 (General Partner, Forest Partners) meeting
- Bio investment landscape insights critical for fundraising strategy
- Understanding investor perspectives before Series A pitch
- Forest Partners potential investor for future rounds
- Investment network expanding beyond angels to institutional VCs
- KAIST Partnership Momentum:
- 임채권 교수 (Visiting Professor/Full Professor, EE, KAIST)
- Discussed Silicon Valley visit - potential for US-Korea collaboration model
- Complements 배현민 (KAIST Startup Center Director) connection from Nov
- Multiple KAIST touchpoints (professor + startup center) = institutional relationship
- KAIST technical credibility valuable for technology validation
- MaiT Commercial Partnership Evolution:
- Beyond just clinical collaboration (Keimyung hospital partnership)
- Discussing technical collaboration for Erudio Bio products with MaiT Health
- MaiT as commercial partner could provide distribution/commercialization pathway
- 이시욱 대표’s dual role (hospital + company) creates synergies
- 한봉주 (QA Lead) involvement indicates serious product development discussions
- Seoul Science High School Network Continuous Investment:
- 설곽인의 밤 (annual SSHS alumni event) attendance
- Alumni network provides long-term support across multiple dimensions
- SSHS alumni in government, industry, academia, finance
- Regular participation maintains visibility and access
- Previous sponsorship (Nov trip) + annual event = comprehensive engagement
- Year-End Timing Strategic:
- December trip allows year-end relationship maintenance before 2026 acceleration
- Conference attendance in December captures professionals before holidays
- Hospital partnerships formalized before new year planning cycles
- Investment discussions seeded for Q1 2026 fundraising
- Momentum maintained through holiday period
- Multi-Hospital Collaboration Model Validation:
- SNUBH model (joint development + IRB + cancer biomarkers) now template
- Keimyung adopting same model but exploring different biomarkers
- Demonstrates scalability - can replicate successful model across institutions
- Different biomarkers per hospital reduces competition, enables cooperation
- Multi-site validation strengthens MFDS approval case
KEY MEETINGS & OUTCOMES
10-Dec-2025 - Arrival & AI-BioX Pre-Conference
4:15pm - Arrival at ICN
7pm-9pm - Evening - AI-BioX ConfEX Pre-Conference Networking Dinner
Location
마노디셰프 삼성점 (Mano di Chef Samsung Branch) 서울 강남구 테헤란로87길 21 동성빌딩 B1층
Key Attendees
- Sunghee Yun
- 김덕호 교수 (Professor and Director, Department of Biomedical Engineering / Center for Microphysiological Systems, Johns Hopkins Medicine)
- 신재영 대표 (CEO, OrganoPlus)
- 원경재 교수 (Associate Professor, Department of Computational Biomedicine, Cedars-Sinai Medical Center)
- 이시연 박사 (K-BioX Representative Operating Committee Member, Stanford Medical School, K-BioX)
- 이해민 의원 (National Assembly Member)
- 최기주 총장 (President, Ajou University)
- 홍회진 대표이사 (CEO, EcoMice)
Outcomes
High-level networking with international institutions (Johns Hopkins, Cedars-Sinai), K-BioX leadership, National Assembly, and university presidents
11-Dec-2025 - AI-BioX ConfEX Grand Summit Day 1
9am-5pm - Full Day Conference Attendance & Networking
Event
AI-BioX ConfEX Grand Summit 2025 Website: https://www.ai-biox.com/
Key Contacts Established (30+ attendees)
International Academia:
- Ahmed Morsy Abdal Dayem (Assistant Professor, Department of Stem Cell & Regenerative Biotechnology, Konkuk University)
- 한남식 교수 (Professor / Ph.D., Milner Therapeutics Institute / Cambridge Centre for AI in Medicine / Cambridge Stem Cell Institute, University of Cambridge)
- 김태형 (Ph.D. / Assistant Professor, Department of Pathology, UNM Health Sciences Center / Cancer Research Facility)
Domestic Academia:
- 김남영 교수 (Professor / Graduate School Dean, Department of Electronic Engineering, Kwangwoon University)
- 김종일 (Director / Department Chair / Professor / Center Director, College of Medicine / Department of Biochemistry & Molecular Biology / Department of Medical Science, SNU Medicine)
- 김인수 (Assistant Professor, Department of Pharmacology / College of Medicine, Chungnam National University)
- 조쌍구 교수 (Professor / Center Director / Department Chair, Department of Stem Cell & Regenerative Engineering / College of Advanced Bioengineering / Molecular Cellular Reprogramming Center, Konkuk University)
- 장서영 (Research Professor, Department of Life Science, Dongguk University)
- 최형진 교수 (Professor / Internal Medicine Specialist / Endocrinology-Metabolism Specialist, Department of Brain and Cognitive Sciences / Department of Anatomy / Department of Medical Science, Seoul National University)
Industry - Biotech/Pharma:
- 권현정 (Director, Business Planning Team, OrganoPlus)
- 김은성 대표 (CEO / CTO, Kims Bio Lab)
- 김용성 (Senior Researcher, Development Division, Vaxdyme)
- 오문주 (Research Director / CTO, GD CORP.)
- 진동환 대표이사 (CEO, MyMeta)
- 홍성현 대표이사 (CEO, Clichembio)
- 서정한 (Business Leader, Genome Analysis Team, Rokit Genomics)
Industry - Investment/Strategy:
- 한상엽 부사장 (Vice President, LSK Investment)
- 황재선 부사장 (Vice President, SK Bioscience Digital Innovation Office, SK Discovery)
- 황주영 상무 (Executive Director, Strategic Planning Division, Revomed)
Government/Institutional:
- 김남희 의원 (National Assembly Member)
- 김성진 팀장 (Team Leader, Economic Free Zone Promotion Team, Suwon City Hall)
- 김지영 (Team Leader, Advanced Industry Promotion Team, Economic Free Zone Promotion Team, Suwon City Hall)
- 황인수 (Official, Economic Free Zone Promotion Team / Advanced Industry Promotion Team, Suwon City Hall)
- 김주연 팀장 (Team Leader, R&D Business Division / Commercialization Support Team, Korea Drug Development Fund)
- 이윤미 (Principal Researcher, R&D Business Division / Commercialization Support Team, Korea Drug Development Fund)
Medical Institutions:
- 박헌준 (Medical Research Office Technology Business Team / Medical Center Industry-Academic Cooperation Foundation Technology Business Team / Korea University Medical Technology Holding Company, Korea University Medical Center)
Media:
- 서일 기자 (Journalist, Editorial Department, BioSpectator)
Event Management:
- 김소윤 (Assistant Manager, MICE Business Division, EcoMice)
- 이재국 팀장 (Team Leader, MICE Business Division, EcoMice)
Learning Outcomes
- Attended presentations on biotech, medical sciences, and AI integration
- Gained insights across stem cell research, drug discovery, computational biomedicine
- Expanded network with Cambridge, Johns Hopkins, SNU, industry leaders
12pm-1pm - VIP Lunch
Format
Exclusive VIP lunch for conference speakers and distinguished guests
6pm-8pm - Networking Dinner - Korea University Medicine
Attendees
- Sunghee Yun
- 고재철 교수 (Professor / M.D., Department of Pain Medicine, Korea University College of Medicine)
- 박재욱 (Technology Transfer Office, Korea University Medicine)
Purpose
Networking with MDs and exploring technology transfer opportunities at Korea University
12-Dec-2025 - AI-BioX ConfEX Grand Summit Day 2 (Final Day)
10am-11:20am - Science & Technology Talent Ecosystem Town Hall Meeting
Participants
- Sunghee Yun
- 황재선 부사장 (Vice President, SK Bioscience Digital Innovation Office, SK Discovery)
- 김남영 교수 (Professor / Graduate School Dean, Department of Electronic Engineering, Kwangwoon University)
- 정재승 교수 (Professor, KAIST)
Discussion Topics
Korea’s science and technology talent ecosystem - education, industry needs, policy frameworks
Outcome
Positioned alongside industry (SK), academia (KAIST, Kwangwoon), and government representatives as ecosystem thought leader
1pm-3pm - Researchthon Judge
Role
Judge for conference Researchthon competition
Responsibility
Evaluated 10 research teams presenting results in biotech, medical science, and AI
Outcome
- Thought leadership positioning as expert evaluator
- Exposure to cutting-edge research from multiple teams
- Network expansion with participating researchers
6pm-8pm - Conference Finale Dinner & Student Mentoring
Activity
Invited to finale dinner where Sunghee mentored numerous students
Outcome
Extended influence to next generation, created talent pipeline for future
13-Dec-2025 - Strategy Session with Jin Young Heo
7pm-9pm - Dinner - Erudio Bio Korea Strategy Discussion
Attendees
- Sunghee Yun
- Jin Young Heo (CLO, Erudio Bio Korea)
CRITICAL DECISIONS MADE
- CRO Search - find and contract Clinical Research Organization (CRO) for SNUBH IRB process
- Daegu Trip Planning - plan Dec 15 visit to Keimyung University Dongsan Hospital to initiate joint development similar to SNUBH model
- LULUMEDIC Partnership - advance partnership discussions with 김영웅 대표
Strategic Impact
CRO decision accelerates IRB approval process across multiple hospital partnerships
14-Dec-2025 - LULUMEDIC Partnership & Hospital Introduction
9am-11am - Brunch with LULUMEDIC
Attendees
- Sunghee Yun
- 김영웅 대표 (President, Korea Digital Health Industry Association / CEO, LULUMEDIC)
Discussion
Potential partnership between Erudio Bio and LULUMEDIC
CRITICAL OUTCOME
김영웅 대표 proposed to introduce 인천송도 나은병원 (Naeun Hospital, Incheon Songdo) for similar partnership model as SNUBH
Strategic Impact
Fourth hospital partnership track opened - Naeun Hospital in strategic Incheon Songdo location
15-Dec-2025 - Keimyung University Dongsan Hospital - PARTNERSHIP FORMALIZATION
12:17pm-1:47pm - Travel to Daegu
KTX 072: Gwangmyeong Station → Dongdaegu Station Travelers: Sunghee Yun, Jin Young Heo
3pm-5pm - Joint Development Partnership Meeting - BREAKTHROUGH
Location
Keimyung University Dongsan Hospital, Daegu
Attendees
- Sunghee Yun
- Jin Young Heo (CLO, Erudio Bio Korea)
- 이시욱 대표이사 (CEO, MaiT / M.D. / Professor, Keimyung University Dongsan Hospital)
- 김도훈 주임교수 (Chief Professor, Department of Laboratory Medicine, Keimyung University)
- 강혜인 교수 (Professor, Department of Laboratory Medicine, Keimyung University)
CRITICAL DECISIONS & OUTCOMES
- Joint development agreement - formalized partnership for biochip medical equipment development for multiplexing cancer biomarker detection (same model as SNUBH)
- Biomarker differentiation - agreed to explore different biomarkers than SNUBH to avoid overlap and enable collaboration
- PoC environment offered - Keimyung proposed providing preliminary testing environment for Proof of Concept
- Laboratory Medicine expertise - 김도훈 (Chief Professor) and 강혜인 (Professor) engagement ensures clinical expertise
Strategic Impact - MAJOR MILESTONE
- Third major hospital partnership formalized (SNUBH, Seoul Asan on track, Keimyung)
- PoC environment de-risks technology validation
- Different biomarkers per hospital creates collaborative rather than competitive network
- Fulfills November promise from 이시욱 to introduce 강혜인 교수
- Daegu regional presence solidified
7:12pm-8:46pm - Return to Seoul Area
KTX 218: Dongdaegu Station → Gwangmyeong Station Travelers: Sunghee Yun, Jin Young Heo
18-Dec-2025 - KAIST Partnership & SNUBH Political Support
12pm-1:30pm - Lunch with KAIST Faculty
Attendees
- Sunghee Yun
- 임채권 교수 (Visiting Professor (Full Professor) / Ph.D. Engineering / Ph.D. Science & Technology Policy, School of Electrical and Electronic Engineering, Korea Advanced Institute of Science and Technology)
Discussion Topics
- 임채권 교수’s upcoming Silicon Valley visit
- Potential partnership between Erudio Bio and KAIST
- US-Korea collaboration models
Outcome
KAIST partnership discussions advanced - complements 배현민 (Startup Center Director) connection
4:30pm-6pm - SNUBH Meeting - NATIONAL ASSEMBLY ENDORSEMENT
Location
Seoul National University Bundang Hospital (SNUBH)
Attendees
- Sunghee Yun
- 김준혁 의원 (National Assembly Member / Deputy Floor Leader, Democratic Party)
- 신원순 (Policy Director, Seoul National University Bundang Hospital)
- 조병주 (Research Administration Team Leader, Seoul National University Bundang Hospital)
- 홍창민 대표이사 (CEO, Animoby)
Sunghee's Presentation
- Working with 이기헌 교수 and team on joint development
- Currently under IRB process
- Developing biochip medical equipment for multiplexing cancer biomarker detection
- Targeting health checkup centers
CRITICAL OUTCOMES
- Strong political endorsement - 김준혁 의원 stated he “understood our technology” and “would help us in whatever way he could”
- Confidence statement - 의원 expressed “utmost confidence in our technology and marketability, product values, profitability, etc.”
- SNUBH Head meeting arranged - 신원순/조병주 will arrange meeting with SNUBH Head for next trip
- SNUBH Head background - Head’s major is 진단검사의학과 (Laboratory Medicine) - perfect alignment
- Stakeholder network created - connected with hospital administrative leadership
Strategic Impact
National Assembly Member endorsement at hospital site demonstrates high-level political support for clinical collaboration
19-Dec-2025 - MaiT Partnership & Alumni Network
5:15pm-6:45pm - Dinner with MaiT Leadership
Attendees
- Sunghee Yun
- 이시욱 대표이사 (CEO, MaiT / M.D. / Professor, Keimyung University Dongsan Hospital)
- 한봉주 (QA Lead, MaiT)
Discussion Topics
- How to proceed with Erudio Bio - Keimyung University Dongsan Hospital collaboration
- Technical collaboration for Erudio Bio products with MaiT Health
Outcome
- Keimyung collaboration execution path clarified
- MaiT product collaboration framework discussed
- Dual clinical + commercial partnership model advancing
7pm-9pm - 설곽인의 밤 (Seoul Science High School Alumni Event)
Event
설곽인의 밤 - Annual Seoul Science High School (SSHS) alumni gathering
Purpose
Strengthen general network with SSHS alumni across government, industry, academia, finance
Outcome
Maintained long-term alumni relationships for sustained support network
20-Dec-2025 - University & Investment Network Expansion
12pm-1pm - Lunch - GACHON UNIVERSITY INTRODUCTION
Attendee
- Sunghee Yun
- 김용석 원장 (Dean, Graduate School of Semiconductor, Gachon University)
Sunghee's Presentation
- Erudio Bio, Inc. overview
- Gates Foundation Award
- SNUBH collaboration
- Keimyung University Dongsan Hospital collaboration
CRITICAL OUTCOME
김용석 원장 proposed to introduce 가천대의대 (Gachon University College of Medicine)!
Strategic Impact
Fifth hospital/medical school partnership track opened - Gachon University adds institutional diversity
4pm-5pm - Coffee Chat with Forest Partners
Attendee
- Sunghee Yun
- 황호연 (General Partner, Forest Partners)
Purpose
- Learn about bio investment landscape
- Build network for potential investment in Erudio Bio
Outcome
- Gained investment landscape intelligence
- Positioned Erudio Bio for future institutional VC funding
- Forest Partners potential investor for Series A or later rounds
FUNDRAISING
Investment Landscape Intelligence
Contact - 황호연 (General Partner, Forest Partners)
Outcome - Bio investment landscape insights, potential investor for future rounds
Timeline - Dec 20, 2025 coffee meeting
Status - Initial meeting, relationship building for future funding rounds
National Assembly Political Support
Contact - 김준혁 의원 (National Assembly Member / Deputy Floor Leader)
Value - Political endorsement provides regulatory advantages and government funding access
Status - Strong endorsement obtained, active support promised
PARTNERSHIP
Keimyung University Dongsan Hospital - FORMALIZED
Contacts
- 이시욱 대표이사 (CEO, MaiT / M.D. / Professor)
- 강혜인 교수 (Professor, Laboratory Medicine)
- 김도훈 주임교수 (Chief Professor, Laboratory Medicine)
Outcome - Joint development partnership formalized, PoC environment secured
Status - Partnership formalized, executing agreement
MaiT (Commercial Partnership)
Contacts
- 이시욱 대표이사 (CEO)
- 한봉주 (QA Lead)
Scope - Technical collaboration for Erudio Bio products, commercial pathway
Status - Active discussions, framework advancing
SNUBH (Seoul National University Bundang Hospital) - INSTITUTIONAL SUPPORT
Administrative Leadership
- 신원순 (Policy Director)
- 조병주 (Research Administration Team Leader)
Political Support
- 김준혁 의원 (National Assembly Member)
Next Step - Meeting with SNUBH Head (진단검사의학과 major)
Status - IRB in progress, institutional support strengthened, Head meeting scheduled
나은병원 (Naeun Hospital, Incheon Songdo) - NEW INTRODUCTION
Introduced by - 김영웅 대표 (CEO, LULUMEDIC)
Location - Incheon Songdo (strategic Incheon Free Economic Zone location)
Status - Introduction secured, initial contact pending
가천대의대 (Gachon University College of Medicine) - NEW INTRODUCTION
Introduced by - 김용석 원장 (Dean, Graduate School of Semiconductor, Gachon University)
Status - Introduction secured, initial contact pending
LULUMEDIC & Korea Digital Health Industry Association
Contact - 김영웅 대표 (President, Korea Digital Health Industry Association / CEO, LULUMEDIC)
Status - Partnership advancing, finalizing terms
KAIST
Contacts
- 임채권 교수 (Visiting Professor, EE)
- 배현민 (Director, KAIST Startup Center / CEO, KAIST Holdings / Professor)
Status - Multiple touchpoints, partnership framework developing
NETWORKING
AI-BioX ConfEX Grand Summit 2025
Scale - 50+ contacts over 2-day conference
International Institutions
- Johns Hopkins Medicine (김덕호 교수)
- University of Cambridge (한남식 교수)
- Cedars-Sinai Medical Center (원경재 교수)
- UNM Health Sciences Center (김태형)
Domestic Universities
- Seoul National University (김종일, 최형진)
- Korea University (고재철, 박재욱)
- KAIST (정재승)
- Konkuk University (Ahmed Morsy, 조쌍구)
- Kwangwoon University (김남영)
- Chungnam National University (김인수)
- Dongguk University (장서영)
Industry - Biotech/Pharma
- OrganoPlus (신재영, 권현정)
- Vaxdyme (김용성)
- Kims Bio Lab (김은성)
- GD CORP (오문주)
- MyMeta (진동환)
- Clichembio (홍성현)
- Rokit Genomics (서정한)
Industry - Corporate
- SK Bioscience/SK Discovery (황재선)
- LSK Investment (한상엽)
- Revomed (황주영)
Government
- National Assembly (이해민 의원, 김남희 의원, 김준혁 의원)
- Suwon City Hall (김지영, 김성진, 황인수)
- Korea Drug Development Fund (김주연, 이윤미)
Media
- BioSpectator (서일 기자)
Gachon University
Contact - 김용석 원장 (Dean, Graduate School of Semiconductor)
Outcome - 가천대의대 introduction secured
Forest Partners
Contact - 황호연 (General Partner)
Focus - Bio investment landscape, potential institutional VC investor
Korea University Medicine
Contacts
- 고재철 교수 (Professor, Pain Medicine)
- 박재욱 (Technology Transfer Office)
Focus - Medical AI collaboration, technology transfer
Seoul Science High School Alumni
Event - 설곽인의 밤 (annual alumni gathering)
Network - Alumni across government, industry, academia, finance
EcoMice (Event Management)
Contact - 홍회진 대표이사 (CEO)
Connection - AI-BioX conference organizer, potential for future events
Ajou University
Contact - 최기주 총장 (President)
Source - AI-BioX pre-conference dinner